Literature DB >> 15814029

Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.

I Adam1, I E A-Elbasit, M I Elbashir.   

Abstract

In late 2003, the efficacies of mefloquine monotherapy and of an artesunate-mefloquine combination, for the oral treatment of uncomplicated, Plasmodium falciparum malaria, were investigated and compared in New Halfa, in eastern Sudan. Of the patients who completed the 28 days of follow-up, 40 were treated only with single-dose mefloquine (at a dose of 25 mg/kg), and 38 with artesunate (at 4 mg/kg. day) for 3 days followed by single-dose mefloquine (at 15 mg/kg), given on the third day. Compared with those given the combination, the patients given mefloquine alone were more likely to suffer nausea, vomiting and dizziness (25.0% v. 2.6%; P=0.005) and to be found gametocytaemic (12.5% v. 0%; P=0.02) after treatment, and more likely to be found febrile (i.e. with a temperature >37.5 degrees C) on day 2 (25.0% v. 2.6%; P=0.005), although no patients were found febrile on day 3. Six of the patients--three (7.5%) of those given mefloquine only and three (7.9%) of those given the combination (P>0.05)--appeared to be treatment failures. Parasite genotyping indicated, however, that, although five of these six patients had true recrudescences, one (who had been treated with the combination) had been re-infected during the follow-up. The true frequencies of cure were therefore 92.5% after mefloquine alone and 94.7% after the combination (P>0.05). Thus, although the treatments appeared equally effective in clearing parasitaemias, the combination was better at clearing gametocytaemias and was less likely to cause adverse side-effects. It remains unclear why mefloquine given alone was almost 10-fold more likely to trigger adverse effects than treatment with a combination that contained the same drug. This may be a reflection of the different mefloquine doses and, for the patients given the combination, of the use of artesunate before the mefloquine treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814029     DOI: 10.1179/136485905X19801

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  7 in total

Review 1.  Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2012

2.  Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Sudan.

Authors:  Sakina Babikir Elamin; Abdelmoneim Ismail Awad; Idris Babiker Eltayeb; Khalid Abdelmutalab Elmardi; Asma Hashim Al Hassan; AbedlRahim Osman Mohamed; Elfatih Mohammad Malik; Tarig Abedelgadir Mohamad
Journal:  Eur J Clin Pharmacol       Date:  2010-03       Impact factor: 2.953

3.  Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria.

Authors:  Félix Tietche; David Chelo; Njiki Kinkela Mina Ntoto; Florence Minjiwa Djoukoue; Christoph Hatz; Sarabel Frey; Adrian Frentzel; Sonja Trapp; Roland Zielonka; Edgar A Mueller
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

4.  Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.

Authors:  Sakina B Elamin; Elfatih M Malik; Tarig Abdelgadir; Ammar H Khamiss; Mamoun M Mohammed; Elderderi S Ahmed; Ishag Adam
Journal:  Malar J       Date:  2005-09-14       Impact factor: 2.979

5.  Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?

Authors:  Yves Jackson; François Chappuis; Louis Loutan; Walter Taylor
Journal:  Malar J       Date:  2006-10-04       Impact factor: 2.979

6.  From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

Authors:  E M Malik; T A Mohamed; K A Elmardi; R M Mowien; A H Elhassan; S B Elamin; A A Mannan; E S Ahmed
Journal:  Malar J       Date:  2006-07-31       Impact factor: 2.979

7.  Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis.

Authors:  Ishag Adam; Yassin Ibrahim; Gasim I Gasim
Journal:  Malar J       Date:  2018-03-13       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.